Literature DB >> 29056081

The Risks and Benefits of Cannabis in the Dermatology Clinic.

Gurbir Dhadwal1, Mark G Kirchhof2.   

Abstract

Cannabis ( Cannabis sativa/indica), also known as marijuana, has been used for medicinal and recreational purposes for millennia. There has been a recent trend to legalize the use of cannabis, as illustrated by the recent legalization votes in numerous states in the United States and legislation in Canada to allow recreational cannabis use. With this increasing consumption of cannabis, dermatologists will see increased pressure to prescribe cannabis and will see the side effects of cannabis use with greater frequency. There are several approved medical indications for cannabis use, including psoriasis, lupus, nail-patella syndrome, and severe pain. In addition, very preliminary studies have suggested cannabis and its derivatives might have use in acne, dermatitis, pruritus, wound healing, and skin cancer. Further well-controlled studies are required to explore these potential uses. Conversely, the side effects of cannabis use are relatively well documented, and dermatologists should be aware of these presentations. Side effects of cannabis use include cannabis allergy manifesting as urticaria and pruritus, cannabis arteritis presenting with necrosis and ulcers, and oral cancers from cannabis smoke. In this review, we summarize some of the studies and reports regarding the medicinal uses of cannabis in the dermatology clinic and some of the side effects that might present more often to dermatologists as the use of cannabis increases.

Entities:  

Keywords:  Cannabis; acne; allergy; arteritis; cancer; dermatitis; medical marijuana; pain; psoriasis

Mesh:

Substances:

Year:  2017        PMID: 29056081     DOI: 10.1177/1203475417738971

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  3 in total

1.  Anti-Neuronal Autoantibodies (Cell Surface and Onconeural) and Their Association With Natural Autoantibodies in Synthetic Cannabinoid-Induced Psychosis.

Authors:  Lídia Hau; Tamás Tényi; Natália László; Márton Áron Kovács; Szabina Erdö-Bonyár; Zsuzsanna Csizmadia; Tímea Berki; Diána Simon; Györgyi Csábi
Journal:  Front Psychiatry       Date:  2022-05-02       Impact factor: 4.157

2.  Medical cannabis dimethyl ether, ethanol and butane extracts inhibit the in vitro growth of bacteria and dermatophytes causing common skin diseases.

Authors:  Tomáš Skala; Zdeˇnka Kahánková; Jan Tauchen; Anežka Janatová; Pavel Klouˇcek; Vít Hubka; Adéla Fraˇnková
Journal:  Front Microbiol       Date:  2022-09-20       Impact factor: 6.064

3.  Commercial Cannabinoid Oil-Induced Stevens-Johnson Syndrome.

Authors:  Han Y Yin; Nicholas Hadjokas; Kanish Mirchia; Robert Swan; Samuel Alpert
Journal:  Case Rep Ophthalmol Med       Date:  2020-02-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.